Dr. Brian E. Lacy

Patient Experience Rating

(4/5) Patient Experience Rating

Gastroenterology

Advanced Endoscopic Interventional + 1 more subspecialties

Jacksonville, FL

Mayo Clinic-Florida

21+ Yrs Experience

Accepting New Patients

Book an Appointment

4500 San Pablo Road S , Jacksonville , FL

Mayo Clinic Jacksonville

Specialties

Subspecialties.

Advanced Endoscopic Interventional

Esophagus Disease

Patient Experience

Provides clear explanation

Makes time for patients

Listens attentively

Practices at Best Hospital

Provides clear information and answers questions in a way patients understand.

Spends appropriate amount of time with patient and provides thorough examinations.

Rated highly on their manner and listening skills.

This doctor practices at a U.S. News Best Regional Hospital

Overall Patient Experience

Very Positive

30 Reviews Total | 9 Reviews Within Last 12 Months

Thoroughness of Examination

Previous patients' satisfaction in their perception of the thoroughness of the examination they received from this physician

Ability to Answer Questions

Previous patients' assessment of this physician's ability to answer all of their questions

Clarity of Instructions

Previous patients' satisfaction in the clarity of this physician's instructions for taking care of their health condition

Provider's follow-up

Previous patients' satisfaction of the followup care they received from this physician and responsiveness to their concerns

Amount of Time with Patient

Previous patients' satisfaction with the time this physician spent with them during appointments

Provider's Attitude

Previous patients' assessment of this physician's friendliness and caring attitude

Perceived Outcomes

Previous patients' satisfaction with the physician's treatment of a condition or outcome of a procedure

Patient Loyalty

Previous patients' trust in this physician, likelihood to see this physician again, or willingness to recommend this physician to another patient

General Feedback

Previous patients' general assessment of this physician

See All Categories

Areas of expertise for dr. lacy.

This doctor provides the following types of care. The more often a doctor has treated a particular condition or has performed a particular surgery, the more expertise they may have in treating patients with similar needs. Based on three years (2020-2022) of Medicare data, each scale below indicates the volume of episodes compared to other doctors who treat the same condition. Click here to learn more about our methodology.

Upper GI endoscopy Upper GI endoscopy is a procedure to visualize and examine the upper digestive tract.

Colonoscopy A colonoscopy is a procedure to visualize and examine the colon for abnormalities.

Acid reflux Acid reflux, aslo known as esophagitis or GERD, occurs when stomach acid flows back into the esophagus, causing a burning sensation in the chest (heartburn).

Looking for something else?

Check to See if Dr. Brian E. Lacy Accepts Your Insurance

Accepts Medicare

Accepts Medicaid

Please contact your provider to confirm if they accept your insurance.

Insurance Carrier

Aetna, Cigna, etc.

Accepted Insurance Plans

Blue Cross and Blue Shield of Kansas City

Blue Cross Blue Shield of Michigan

CMS Medicare

VT State Medicaid

Don`t see your plan listed? Click here to find providers that accept your insurance .

Gastroenterologists Like Dr. Lacy Near Me

Kenneth DeVault MD

Jacksonville , FL

Kenneth DeVault MD

Maria Yataco MD

Maria Yataco MD

Ernest Bouras MD

Ernest Bouras MD

Timothy Woodward MD

Timothy Woodward MD

Location & Contact Information

Doctor Address

4500 San Pablo Road S, Jacksonville, FL, 32224

Affiliated Hospitals

Where does Dr. Lacy practice?

Doctor’s office.

Here are other providers that practice at the same doctor's office:

Paul Pettit

Obstetrics & Gynecology

Stephanie Faubion

Internal Medicine

Maoyin Pang

Paul Lascuna

Family Nurse Practitioner

Kensler Jackson

Family Medicine

Herbert Wolfsen

Lindsy Williams

Elizabeth Shuster

Shehzad Niazi

Adrian Dumitrascu

Amit Merchea

Colon & Rectal Surgery

Eric Loveless

Orthopedics

Emir Festic

Pulmonology

Gerardo Colon-Otero

Pragnesh Parikh

Brian Grimard

Emergency Medicine

Julio Gundian

Chandler Dora

Matthew Crowe

Hospital Affiliations

Mayo clinic-florida jacksonville, fl.

# 24 in Gastroenterology & GI Surgery

High Performing in Colon Cancer Surgery

Education & Experience

Medical school & residency.

Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital

Fellowship , Gastroenterology , 1995 - 1997

University of Maryland School of Medicine

Medical School

Residency , Internal Medicine , 1991 - 1995

Certifications & Licensure

American Board of Internal Medicine

Certified in Gastroenterology

FL State Medical License

Active through 2024

MD State Medical License

Active through 2004

NH State Medical License

Active through 2018

Publications

Irritable bowel syndrome - less irritable, or better treatments?

Travers, P., Lacy, B., Cangemi, D.

Gastroparesis: time for a paradigm change.

Brian E Lacy, Journey L Wise, David J Cangemi

Virtual Reality Improves Symptoms of Functional Dyspepsia: Results of a Randomized, Double-Blind, Sham-Controlled, Pilot Study.

David J Cangemi, Marilia Montenegro, Brennan M R Spiegel, And Brian E Lacy

Misdiagnosis of Gastroparesis is Common: A Retrospective Review of Patients Referred to a Tertiary Gastroenterology Practice.

David J Cangemi, Lilly Stephens, Brian E Lacy

Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.

Brian E Lacy, Lin Chang, Satish S C Rao, Zeev Heimanson, Gregory S Sayuk

De-escalate Don't Escalate: Essential Steps to Effectively Recognize and Manage the Patient Who Is Angry and Disruptive.

Brian E Lacy, Laurie Keefer, Douglas A Drossman

Virtual Reality: A New Treatment Paradigm for Disorders of Gut-Brain Interaction?

Brian E Lacy, David J Cangemi, Brennan R Spiegel

Gastroparesis: Myths, Misconceptions, and Management.

David J Cangemi, Brian E Lacy

The treatment of functional dyspepsia: present and future.

Brian E Lacy, R Christopher Chase, David J Cangemi

How Your Writing Can Succeed: Getting a Manuscript Accepted by The American Journal of Gastroenterology

George F Longstreth, Heather M Patton, Brian E. Lacy

Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes

Himesh Zaver, Hassan Ghoz, Balkishan Malviya, Bhaumik Brahmbhatt, William C. Palmer, Brian E. Lacy, Kenneth R. DeVault, Murli Krishna, Yan Bi

70-Year-Old Man With Chronic Nausea and Vomiting.

Varun Moktan, Kimberly Robelin, Brian E. Lacy

AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review

Brian E. Lacy, Jan Tack, C. Prakash Gyawali

The Changing Landscapes" Special Edition."

Brian E. Lacy, Brennan Spiegel

Gastric Emptying Scans: Poor Adherence to National Guidelines

Journey Wise, Maria I. Vazquez-Roque, Caleb J. McKinney, Michael A. Zickella, Michael D. Crowell, Brian E. Lacy

Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.

Lin Chang, Brian E. Lacy, Baha Moshiree, Amy Kassebaum, Jessica L. Abel, Jennifer Hanlon, Wilmin Bartolini, Ramesh Boinpally, Wieslaw Bochenek, Susan M. Fox, Madhuja Mallick, Ken Tripp, Nicholas Omniewski, Elizabeth P. Shea, Niels Borgstein

Controversies in Gastroparesis: Discussing the Sticky Points.

Brian E. Lacy, David J. Cangemi

Extent of eosinophilic esophagitis predicts response to treatment

Hassan Ghoz, Fernando F. Stancampiano, Jose Valery, Katie Nordelo, Balkishan Malviya, Brian E. Lacy, Dawn L. Francis, Kenneth R. DeVault, Ernest P. Bouras, Murli Krishna, William C. Palmer

Pyloric dilation with EsoFLIP: Time to "flip" treatment options for refractory gastroparesis?

Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply.

Alfred D. Nelson, Christopher J Black, Lesley A. Houghton, Nahyr Sofía Lugo-Fagundo, Brian E. Lacy, Alexander C. Ford

Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation.

Eating Disorders: Diagnosis and Management Considerations for the IBD Practice.

Graziella Rangel Paniz, Jocelyn Lebow, Leslie Sim, Brian E. Lacy, Francis A Farraye, Monia E. Werlang

Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates

David J. Cangemi, Brian E. Lacy, Journey Wise

Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data.

Brian E. Lacy, Darren M. Brenner, William D. Chey

Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.

Eric D. Shah, Brian E. Lacy, William D. Chey, Lin Chang, Darren M. Brenner

Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options.

Darren M. Brenner, Brian E. Lacy

Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change.

Brooks D. Cash, Brian E. Lacy, Cheryl Watton, Philip Schoenfeld, Darren Weissman

Satiation or satiety? More than mere semantics – Authors' reply

M Florencia Carbone, Sanjiv Mahadeva, Brian E. Lacy, Nicholas J. Talley, Alexander C. Ford

Gastric POEM for gastroparesis: Panacea, placebo, or pathway to the future?

Management of irritable bowel syndrome with diarrhea: focus on eluxadoline

Jennifer Jones, Anthony Lembo, Joel J. Heidelbaugh, Louis Kuritzky, Brian E. Lacy

Gastroparesis and Severity of Delayed Gastric Emptying: Comparison of Patient Characteristics, Treatments and Medication Adverse Events.

Christopher M. Navas, Erica D. Wadas, Natalia H. Zbib, Michael D. Crowell, Brian E. Lacy

Management of Chronic Abdominal Distension and Bloating

Brian E. Lacy, David J. Cangemi, Maria I. Vazquez-Roque

Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications

Brian E. Lacy, Elizabeth P. Shea, Machelle Manuel, Jessica L. Abel, Hancheng Jiang, Douglas C.A. Taylor

Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief.

Shawn L. Shah, Nigeen H. Janisch, Michael D. Crowell, Brian E. Lacy

ACG Clinical Guideline: Management of Irritable Bowel Syndrome.

Brian E. Lacy, Mark Pimentel, Darren M. Brenner, William D. Chey, Laurie Keefer, Millie D. Long, Baha Moshiree

Update on Irritable Bowel Syndrome Guidelines.

Brian E. Lacy

Postobesity Surgery Esophageal Dysfunction: A Combined Cross-Sectional Prevalence Study and Retrospective Analysis

Alexander T. Miller, Reem Matar, Barham K. Abu Dayyeh, Azizullah Beran, Marcelo F. Vela, Brian E. Lacy, Michael D. Crowell, Debra M. Geno, Crystal Lavey, David A. Katzka, Karthik Ravi

Mechanisms, Evaluation, and Management of Chronic Constipation

Adil E. Bharucha, Brian E. Lacy

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions

David J. Cangemi, Brian E. Lacy

Patient-Centric Care of Diarrhea-Predominant Irritable Bowel Syndrome.

Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.

Diana L. Snyder, Michael D. Crowell, Jennifer L. Horsley-Silva, Karthik Ravi, Brian E. Lacy, Marcelo F. Vela

Gastrointestinal Manifestations of Rheumatological Diseases

Paul T. Kroner, Omar A. Tolaymat, Andrew W. Bowman, Andy Abril, Brian E. Lacy

Introduction to the Gut Microbiome Special Issue.

Response to Lai.

Brooks D. Cash, Brian E. Lacy, Philip Schoenfeld, Leonard S. Dove, Paul S. Covington

Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores.

Brian E. Lacy, Kelly Everhart, Michael D. Crowell

Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors’ reply

Alexander C. Ford, Lucinda A. Harris, Brian E. Lacy, Eamonn Martin Quigley, Paul Moayyedi

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.

Brian E. Lacy, Lucinda A. Harris, Lin Chang, Susan Lucak, Catherine Gutman, Leonard S. Dove, Paul S. Covington, Anthony Lembo

A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial.

William D. Chey, Brian E. Lacy, Brooks D. Cash, Michael P. Epstein, Patrick Corsino, Syed M. Shah

Update on the management of chronic idiopathic constipation.

The willingness of patients with gastroparesis to take risks with medications.

Christopher M. Navas, Michael D. Crowell, Brian E. Lacy

Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials.

Rapat Pittayanon, Yuhong Yuan, Natasha Bollegala, Reena Khanna, Brian E. Lacy, Christopher N. Andrews, Grigorios I. Leontiadis, Paul Moayyedi

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Alexander C. Ford, Brian E. Lacy, Lucinda A. Harris, Eamonn Martin Quigley, Paul Moayyedi

The Challenges of Gastroparesis: Changing Study Design to Improve Clinical Care.

Brian E. Lacy, Michael D. Crowell, Michael Camilleri

Irritable Bowel Syndrome and Dietary Interventions.

Monia E. Werlang, William C. Palmer, Brian E. Lacy

Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome.

Brian E. Lacy, Rajeev Ayyagari, Annie Guerin, Andrea Lopez, Sherry Shi, Michelle Luo

Symptomatic Management of Gastroparesis.

Christopher M. Navas, Nihal Patel, Brian E. Lacy

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.

Introduction to the 80% by 2018 Special Issue

Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome.

American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.

Alexander C. Ford, Paul Moayyedi, William D. Chey, Lucinda A. Harris, Brian E. Lacy, Yuri A. Saito, Eamonn Martin Quigley

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint:

Brian E. Lacy, Jean Paul Nicandro, Emil Chuang, David L. Earnest

Management Options for Patients with GERD and Persistent Symptoms on Proton Pump Inhibitors: Recommendations from an Expert Panel

Rena Yadlapati, Michael F. Vaezi, Marcelo F. Vela, Stuart J. Spechler, Nicholas J. Shaheen, Joel E. Richter, Brian E. Lacy, David A. Katzka, Philip O. Katz, Peter J. Kahrilas, C. Prakash Gyawali, Lauren B. Gerson, Ronnie Fass, Donald O. Castell, Jenna Craft, Luke Hillman, John E. Pandolfino

Chronic nausea and vomiting: evaluation and treatment.

Brian E. Lacy, Henry P. Parkman, Michael Camilleri

Response to Marlicz et al.

Paul Moayyedi, Brian E. Lacy, Christopher N. Andrews, Robert A Enns, Colin W Howden, Nimish Vakil

Quality of Care and the Irritable Bowel Syndrome: Is Now the Time to Set Standards?

Brian E. Lacy, Alexander C. Ford, Nicholas J. Talley

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Philip Schoenfeld, Brian E. Lacy, William D. Chey, Anthony Lembo, Caroline B. Kurtz, David S. Reasner, Wieslaw Bochenek, Kenneth Tripp, Mark G. Currie, Susan M. Fox, Rick Blakesley, Christopher R. O'Dea, Nicholas Omniewski, Michael Hall

Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD)

Fiona Taylor, Sophie Higgins, Robyn T. Carson, Sonya Eremenco, Catherine Foley, Brian E. Lacy, Henry P. Parkman, David S. Reasner, Alan L. Shields, Jan Tack, Nicholas J. Talley

Putting Patients First.

Brennan Spiegel, Brian E. Lacy

No Results? No Problem! Why We Are Publishing Methods of a Landmark Study With Results Still Pending

A System to Assess the Competency for Interpretation of Esophageal Manometry Identifies Variation in Learning Curves

Rena Yadlapati, Rajesh N. Keswani, Jody D. Ciolino, David Grande, Zoe Listernick, Dustin A. Carlson, Donald O. Castell, Kerry B. Dunbar, Andrew J. Gawron, C. Prakash Gyawali, Philip O. Katz, David A. Katzka, Brian E. Lacy, Stuart J. Spechler, Roger P. Tatum, Marcelo F. Vela, John E. Pandolfino

Safety of Eluxadoline in Patients with IBS-D Without a Gallbladder

Response to Croteau and Barkin.

Gastroparesis: Medical and Therapeutic Advances

ACG and CAG Clinical Guideline: Management of Dyspepsia

Paul Moayyedi, Brian E. Lacy, Christopher N. Andrews, Robert Enns, Colin W. Howden, Nimish Vakil

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use

Brian E. Lacy, William D. Chey, Brooks D. Cash, Anthony Lembo, Leonard S. Dove, Paul S. Covington

Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial.

Yuri A. Saito, G. Richard Locke, Ann E. Almazar, Ernest P. Bouras, Colin W. Howden, Brian E. Lacy, John K. DiBaise, Charlene M. Prather, Bincy Abraham, Hashem B. El-Serag, Paul Moayyedi, Linda M. Herrick, Lawrence A. Szarka, Michael Camilleri, Frank A. Hamilton, Cathy D. Schleck, Katherine E. Tilkes, Alan R. Zinsmeister, Nicholas J. Talley

Hot Topics in Primary Care: Role of the Microbiome in Disease: Implications for Treatment of Irritable Bowel Syndrome.

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.

Update on the Management of Chronic Constipation

Jenna L. Koliani-Pace, Brian E. Lacy

Anatomy and Physiology of the Small Bowel

Neil R. Volk, Brian E. Lacy

Negative Is Positive.

Dietary Interventions and Irritable Bowel Syndrome: A Review of the Evidence

Shawn L. Shah, Brian E. Lacy

Bowel Disorders.

Fermín Mearin, Brian E Lacy, Lin Chang, William D Chey, Anthony J Lembo, Magnus Simren, Robin Spiller

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome.

Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?

Brooks D. Cash, Brian E. Lacy, Tharaknath Rao, David L. Earnest

The American Journal of Gastroenterology in 2016: Where Have We Been? Where Are We Going?

Neuroenteric Stimulation for Gastroparesis

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum.

Zilla H Hussain, Emily E Henderson, Carla Maradey-Romerao, Nina George, Ronnie Fass, Brian E Lacy

Opioid-Induced Esophageal Dysfunction (OIED) in patients on chronic opioids

Shiva K. Ratuapli, Michael D. Crowell, John K. DiBaise, Marcelo F. Vela, Francisco C. Ramirez, George E. Burdick, Brian E. Lacy, Joseph A. Murray

New and Emerging Treatment Options for Irritable Bowel Syndrome

Brian E. Lacy, William D. Chey, Anthony Lembo

Medication Risk-Taking Behavior in Functional Dyspepsia Patients

Brian E. Lacy, Jerry Yu, Michael D. Crowell

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.

Alexander C. Ford, Eamonn Martin Quigley, Brian E. Lacy, Anthony Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan Spiegel, Paul Moayyedi

The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis

Paul Moayyedi, Eamonn Martin Quigley, Brian E. Lacy, Anthony Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan Spiegel, Alexander C. Ford

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

Alexander C. Ford, Paul Moayyedi, Brian E. Lacy, Anthony Lembo, Yuri A. Saito, Lawrence R. Schiller, Edy E. Soffer, Brennan Spiegel, Eamonn Martin Quigley

Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

On-demand hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain.

Brian E. Lacy, Fei Wang, Sujata Bhowal, Eckhard Schaefer

Functional Dyspepsia and Gastroparesis: One Disease or Two?

Chronic constipation: new diagnostic and treatment approaches.

Brian E. Lacy, John M. Levenick, Michael D. Crowell

Recent Advances in the Management of Difficult Constipation

IBS patients' willingness to take risks with medications.

Brian E. Lacy, Kelly Everhart, Kirsten Weiser, Ryan DeLee, Sebastian Strobel, Corey A. Siegel, Michael D. Crowell

A Prospective Study to Compare a Symptom-Based Reflux Disease Questionnaire to 48-h Wireless pH Monitoring for the Identification of Gastroesophageal Reflux (revised 2-26-11)

Brian E. Lacy, Robert Chehade, Michael D. Crowell

Functional dyspepsia is associated with sleep disorders.

Clinical utility of the wireless pH capsule.

Brian E. Lacy, Andrew C. Dukowicz, Douglas J. Robertson, Julia E. Weiss, Pedro Teixeira, Maurice L. Kelley

Functional dyspepsia: time to change clinical trial design?

Brian E. Lacy, Nicholas J. Talley, Michael Camilleri

The Diagnosis of Gastroesophageal Reflux Disease

Brian E. Lacy, Kirsten Weiser, Jocelyn D. Chertoff, Ronnie Fass, John E. Pandolfino, Joel E. Richter, Richard I. Rothstein, Chad Spangler, Michael F. Vaezi

Prucalopride for chronic constipation.

Brian E. Lacy, Burr J. Loew, Michael D. Crowell

The clinical utility of esophageal manometry.

Brian E. Lacy, Lisa Paquette, Douglas J. Robertson, Maurice L. Kelley, Julia E. Weiss

Common anorectal disorders: Diagnosis and treatment

Brian E. Lacy, Kirsten Weiser

Tolerability and clinical utility of the Bravo pH capsule in children.

Brian E. Lacy, Susan Edwards, Lisa Paquette, Julia E. Weiss, Maurice L. Kelley, Kim Ornvold

The treatment of irritable bowel syndrome.

Brian E. Lacy, Kirsten Weiser, Ryan De Lee

Lubiprostone: chronic constipation and irritable bowel syndrome with constipation

Brian E. Lacy, William D. Chey

How effective is tegaserod for the treatment of female patients with mixed subtype IBS

Lubiprostone: a novel treatment for chronic constipation.

Brian E. Lacy, L. Campbell Levy

Esophageal motility disorders: medical therapy

The effects of nebulized albuterol on esophageal function in asthmatic patients.

Brian E. Lacy, Carole Mathis, John DesBiens, Mark C. Liu

A 32-year-old woman with chronic abdominal pain.

Brian E. Lacy, Brooks D. Cash

Lubiprostone : A chloride channel activator

Safety and Tolerability of Transoral Bravo Capsule Placement After Transnasal Manometry Using a Validated Conversion Factor

Brian E. Lacy, Tracia O'Shana, Mary L. Hynes, Maurice L. Kelley, Julia E. Weiss, Lisa Paquette, Richard I. Rothstein

Gastrointestinal Motility Disorders: An Update

Gastric motility, gastroparesis, and gastric stimulation.

Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior.

Brian E. Lacy, Michael D. Crowell, Randal P Riesett, Amy M. Mitchell

Irritable bowel syndrome: a syndrome in evolution.

Brian E. Lacy, Ryan De Lee

Partnering With Gastroenterologists to Evaluate Patients With Chronic Constipation

Brian E. Lacy, Stephen A. Brunton

Irritable bowel syndrome: a primer on management.

Botulinum toxin for the treatment of gastroparesis: a preliminary report

Brian E. Lacy, Estephan N. Zayat, Michael D. Crowell, Marvin M. Schuster

Case Report: Botulinum Toxin in Hypertensive Lower Esophageal Sphincter: A Manometric Case Study

Brian E. Lacy, Estephan N. Zayat, Michael D. Crowell

Tegaserod: a new 5-HT4 agonist.

Brian E. Lacy, Shaoyong Yu

Frequently Asked Questions About Dr. Lacy

Can i make an appointment online with dr. lacy , does dr. lacy offer telehealth, what do patients say about dr. lacy , dr. lacy accepts insurance, where is dr. lacy's office located, what are dr. lacy's areas of care.

Let us know if this information is out of date or incorrect.

Are you Dr. Brian E. Lacy ?

brian e. lacy md phd jacksonville

Living Well With

brian e. lacy md phd jacksonville

Tips for Relieving Daily Stress and Calming Down

brian e. lacy md phd jacksonville

Ulcer Diet: Foods to Eat and Avoid

brian e. lacy md phd jacksonville

What Are the Best Foods for Ulcerative Colitis?

health disclaimer »

Disclaimer and a note about your health », you may also like, breast cancer and diet: foods to eat.

Elaine K. Howley Dec. 18, 2023

brian e. lacy md phd jacksonville

7 Ways to Spot a Magnesium Deficiency

Elaine K. Howley Dec. 15, 2023

brian e. lacy md phd jacksonville

How to Get Rid of Cold and Flu

Elaine K. Howley Dec. 13, 2023

brian e. lacy md phd jacksonville

Medicare Part B: What It Covers

Paul Wynn Dec. 6, 2023

brian e. lacy md phd jacksonville

Does Medicare Cover Eye Exams?

Elaine K. Howley Dec. 5, 2023

brian e. lacy md phd jacksonville

Maternity Care Access Options

Jennifer Winston, Ph.D. and Ben Harder Dec. 5, 2023

brian e. lacy md phd jacksonville

Medicare Coverage for Hearing Aids 2024

Paul Wynn Dec. 4, 2023

brian e. lacy md phd jacksonville

Does Medicare Cover Cataract Surgery?

Elaine K. Howley Dec. 4, 2023

brian e. lacy md phd jacksonville

Ways to Induce Labor

Payton Sy Nov. 30, 2023

brian e. lacy md phd jacksonville

How to Talk to People With Chronic Pain

Stacey Colino Nov. 30, 2023

brian e. lacy md phd jacksonville

  • Professions
  • Physician Assistants
  • Nurse Practitioners
  • Pharmacists
  • Optometric Practitioners
  • Genetic Counselors
  • Case Managers
  • Psychologists
  • Social Worker
  • Allergy/Immunology
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Infectious Disease
  • Internal Medicine
  • Mental Health
  • continuation
  • OB/GYN & Women's Health
  • Ophthalmology
  • Otolaryngology
  • Public Health & Prevention
  • Pulmonary Medicine
  • Rheumatology
  • State Required CME
  • Advanced Topics
  • Managed Care & Specialty Pharmacy
  • COVID-19 Center
  • Subscriptions

Brian E. Lacy, Ph.D., M.D., FACG

Brian E. Lacy, Ph.D., M.D., FACG

Professor of Medicine, Mayo Clinic, Jacksonville

Activity Affiliations

  • April 12, 2023 The Many Faces of Irritable Bowel Syndrome With Constipation: Incorporating Patient Perspectives Into Decisions Regarding Their Care

PRIME Education

Advancing the science of learning and behavior change in health care

PRIME Education

  • Access PRIME's extensive catalog of free CME/CE activities
  • Stay up-to-date with free online and live activities
  • Track, download, and submit CME/CE credits with ease

Information required to claim credit

We need this information to award CME credit for this and future activities.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Brian E. Lacy, M.D., Ph.D.

  • Gastroenterologist
  • Neurogastroenterologist
  • Publications
  • Byale A, Lennon RJ, Byale S, Breen-Lyles M, Edwinson AL, Gupta R, Lacy BE , Olson JE, Houghton LA, Grover M. High-Dimensional Clustering of 4000 Irritable Bowel Syndrome Patients Reveals Seven Distinct Disease Subsets. Clin Gastroenterol Hepatol. 2024 Jan; 22 (1):173-184.e12 Epub 2022 Sept 27 View PubMed
  • Cangemi DJ, Montenegro M, Spiegel BMR, Lacy ABE, Lacy BE . Virtual Reality Improves Symptoms of Functional Dyspepsia: Results of a Randomized, Double-Blind, Sham-Controlled, Pilot Study. Am J Gastroenterol. 2024 Jan 1; 119 (1):210-213 Epub 2023 Sept 01 View PubMed
  • Travers P, Lacy BE , Cangemi DJ. Irritable bowel syndrome - less irritable, or better treatments? Curr Opin Gastroenterol. 2024 Jan 1; 40 (1):27-33 Epub 2023 Oct 19 View PubMed
  • Lacy BE , Wise JL, Cangemi DJ. Gastroparesis: time for a paradigm change. Curr Opin Gastroenterol. 2023 Nov 1; 39 (6):503-511 Epub 2023 Sept 05 View PubMed
  • Cangemi DJ, Stephens L, Lacy BE . Misdiagnosis of Gastroparesis is Common: A Retrospective Review of Patients Referred to a Tertiary Gastroenterology Practice. Clin Gastroenterol Hepatol. 2023 Sep; 21 (10):2670-2672.e3 Epub 2023 Feb 03 View PubMed
  • Wise JL, Ingrosso MR, Ianiro G, Black CJ, Ford AC, Lacy BE . Response and Adverse Event Rates With Placebo in Gastroparesis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2023 Jun; 21 (6):1447-1461 Epub 2022 Oct 19 View PubMed
  • Brenner DM, Lacy BE , Ford AC, Bartolini W, Wu J, Shea EP, Bochenek W, Boinpally R, Almansa C. Linaclotide Reduced Response Time for Irritable Bowel Syndrome With Constipation Symptoms: Analysis of 4 Randomized Controlled Trials. Am J Gastroenterol. 2023 May 1; 118 (5):872-879 Epub 2022 Oct 12 View PubMed
  • Lacy BE , Keefer L, Drossman DA. De-escalate Don't Escalate: Essential Steps to Effectively Recognize and Manage the Patient Who Is Angry and Disruptive. Am J Gastroenterol. 2023 Mar 1; 118 (3):386-388 Epub 2022 Dec 07 View PubMed
  • Lacy BE , Chang L, Rao SSC, Heimanson Z, Sayuk GS. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points. Clin Ther. 2023 Mar; 45 (3):198-209 Epub 2023 Mar 14 View PubMed
  • Lacy BE , Cangemi DJ, Spiegel BR. Virtual Reality: A New Treatment Paradigm for Disorders of Gut-Brain Interaction? Gastroenterol Hepatol (N Y). 2023 Feb; 19 (2):86-94 View PubMed
  • Lacy BE , Chase RC, Cangemi DJ. The treatment of functional dyspepsia: present and future. Expert Rev Gastroenterol Hepatol. 2023 Jan; 17 (1):9-20 Epub 2023 Jan 01 View PubMed
  • Quigley EMM, Markinson L, Stevenson A, Treasure FP, Lacy BE . Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2023 Jan; 57 (1):81-93 Epub 2022 Nov 11 View PubMed
  • Cangemi DJ, Lacy BE . Gastroparesis: Myths, Misconceptions, and Management. Clin Exp Gastroenterol. 2023; 16:65-78 Epub 2023 June 06 View PubMed
  • Lacy BE , King J, Shortino D, Schaumburg C, Haag-Molkenteller C, Chey WD. Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial. Neurogastroenterol Motil. 2022 Dec; 34 (12):e14448 Epub 2022 Aug 16 View PubMed
  • Rao SSC, Lacy BE , Emmanuel A, Muller-Lissner S, Pohl D, Quigley EMM, Whorwell P. Recognizing and Defining Occasional Constipation: Expert Consensus Recommendations. Am J Gastroenterol. 2022 Nov 1; 117 (11):1753-1758 Epub 2022 Aug 12 View PubMed
  • Lacy BE , Cangemi DJ. Updates in functional dyspepsia and bloating. Curr Opin Gastroenterol. 2022 Nov 1; 38 (6):613-619 View PubMed
  • Lacy BE , Cangemi DJ, Wise JL, Crowell MD. Development and validation of a novel scoring system for bloating and distension: The Mayo Bloating Questionnaire. Neurogastroenterol Motil. 2022 Aug; 34 (8):e14330 Epub 2022 Feb 24 View PubMed
  • Rangel Paniz G, Lebow J, Sim L, Lacy BE , Farraye FA, Werlang ME. Eating Disorders: Diagnosis and Management Considerations for the IBD Practice. Inflamm Bowel Dis. 2022 Jun 3; 28 (6):936-946 View PubMed
  • Lacy BE , Cangemi DJ. A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating. Am J Gastroenterol. 2022 May 1; 117 (5):701-705 Epub 2022 Jan 29 View PubMed
  • Crowell MD, Umar SB, Lacy BE , Jones MP, DiBaise JK. factorial structure, validity and internal consistency of the multi dimensional gastrointestinal symptoms severity index (GISSI) Dig Dis Sci 2015. 2015; 60:2270-2279.
  • Lacy BE , Brenner DM, Chey WD. Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data. Clin Gastroenterol Hepatol. 2022 Apr; 20 (4):e682-e695 Epub 2021 May 25 View PubMed
  • Lacy BE , Chey WD, Epstein MS, Shah SM, Corsino P, Zeitzoff LR, Cash BD. A novel duodenal-release formulation of caraway oil and L-menthol is a safe, effective and well tolerated therapy for functional dyspepsia. BMC Gastroenterol. 2022 Mar 7; 22 (1):105 Epub 2022 Mar 07 View PubMed
  • Lacy BE , Tack J, Gyawali CP. AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review. Clin Gastroenterol Hepatol. 2022 Mar; 20 (3):491-500 Epub 2021 Oct 29 View PubMed
  • Cangemi DJ, Lacy BE . A Practical Approach to the Diagnosis and Treatment of Abdominal Bloating and Distension. Gastroenterol Hepatol (N Y). 2022 Feb; 18 (2):75-84 View PubMed
  • Longstreth GF, Patton HM, Lacy BE . How Your Writing Can Succeed: Getting a Manuscript Accepted by The American Journal of Gastroenterology. Am J Gastroenterol. 2022 Jan 1; 117 (1):11-15 View PubMed
  • Montenegro M, Werlang M, Nelson A, Lacy BE . High Resolution Esophageal Manometry in Asthmatics Submitted. 2022.
  • Longstreth GF, Patton HM, Lacy BE . Achieving manuscript acceptance by the American Journal of Gastroenterology: advice to authors based on an anylysis of reasons for rejection AM J Gastroenterol. 2022; 117:11-15.
  • Cid-Ruzafa J, Lacy BE , Schultze A, Duong M, Lu Y, Raluy-Callado M, Donaldson R, Weissman D, Gomez-Lumbreras A, Ouchi D, Giner-Soriano M, Morros R, Ukah A, Pohl D. Linaclotide utilization and potential for off-label use and misuse in three European countries. Therap Adv Gastroenterol. 2022; 15:17562848221100946 Epub 2022 June 11 View PubMed
  • Lacy BE , Crowell MD, Cangemi DJ, Lunsford TN, Simren M, Tack J. Diagnostic Evaluation of Gastric Motor and Sensory Disorders. Am J Gastroenterol. 2021 Dec 1; 116 (12):2345-2356 View PubMed
  • Moktan VP, Robelin K, Lacy BE . 70-Year-Old Man With Chronic Nausea and Vomiting. Mayo Clin Proc. 2021 Dec; 96 (12):3142-3146 Epub 2021 Oct 30 View PubMed
  • Cangemi DJ, Lacy BE . Gastroparesis. Curr Opin Gastroenterol. 2021 Nov 1; 37 (6):596-601 View PubMed
  • Zaver HB, Ghoz H, Malviya BJ, Brahmbhatt B, Palmer WC, Lacy BE , DeVault KR, Krishna M, Bi Y. Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes. Dig Dis Sci. 2021 Nov; 66 (11):3976-3984 Epub 2020 Nov 20 View PubMed
  • Lacy BE , Spiegel B. The "Changing Landscapes" Special Edition. Am J Gastroenterol 2021 Oct 1; 116 (10):1969 View PubMed
  • Wise JL, Vazquez-Roque MI, McKinney CJ, Zickella MA, Crowell MD, Lacy BE . Gastric Emptying Scans: Poor Adherence to National Guidelines. Dig Dis Sci. 2021 Sep; 66 (9):2897-2906 Epub 2020 May 16 View PubMed
  • Chang L, Lacy BE , Moshiree B, Kassebaum A, Abel JL, Hanlon J, Bartolini W, Boinpally R, Bochenek W, Fox SM, Mallick M, Tripp K, Omniewski N, Shea E, Borgstein N. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. Am J Gastroenterol. 2021 Sep 1; 116 (9):1929-1937 View PubMed
  • Ghoz H, Stancampiano FF, Valery JR, Nordelo K, Malviya B, Lacy BE , Francis D, DeVault K, Bouras E, Krishna M, Palmer WC. Extent of eosinophilic esophagitis predicts response to treatment. Endosc Int Open. 2021 Aug; 9 (8):E1234-E1242 Epub 2021 July 16 View PubMed
  • Lacy BE , Cangemi DJ. Controversies in Gastroparesis: Discussing the Sticky Points. Am J Gastroenterol. 2021 Aug 1; 116 (8):1572-1576 View PubMed
  • Brenner DM, Lacy BE . Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options. Am J Gastroenterol. 2021 Aug 1; 116 (8):1587-1600 View PubMed
  • Shah ED, Lacy BE , Chey WD, Chang L, Brenner DM. Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials. Am J Gastroenterol. 2021 Aug 1; 116 (8):1601-1611 View PubMed
  • Nelson AD, Black CJ, Houghton LA, Lugo-Fagundo NS, Lacy BE , Ford AC. Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2021 Jul; 54 (2):98-108 Epub 2021 June 11 View PubMed
  • Cangemi DJ, Lacy BE , Wise J. Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates. Dig Dis Sci. 2021 Jun; 66 (6):2042-2050 Epub 2020 July 17 View PubMed
  • Jones J, Lembo A, Heidelbaugh J, Kuritzky L, Lacy B . Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Curr Med Res Opin. 2021 Apr; 37 (4):567-578 Epub 2021 Mar 03 View PubMed
  • Navas CM, Wadas ED, Zbib NH, Crowell MD, Lacy BE . Gastroparesis and Severity of Delayed Gastric Emptying: Comparison of Patient Characteristics, Treatments and Medication Adverse Events. Dig Dis Sci. 2021 Feb; 66 (2):526-534 Epub 2020 Apr 18 View PubMed
  • Lacy BE , Cangemi D, Vazquez-Roque M. Management of Chronic Abdominal Distension and Bloating. Clin Gastroenterol Hepatol. 2021 Feb; 19 (2):219-231.e1 Epub 2020 Apr 01 View PubMed
  • Shah SL, Janisch NH, Crowell M, Lacy BE . Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief. Clin Gastroenterol Hepatol. 2021 Jan; 19 (1):80-86 Epub 2020 Apr 11 View PubMed
  • Lacy BE , Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021 Jan 1; 116 (1):17-44 View PubMed
  • Cash BD, Lacy BE , Watton C, Schoenfeld PS, Weissman D. Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change. Therap Adv Gastroenterol. 2021; 14:17562848211001725 Epub 2021 Apr 10 View PubMed
  • Lacy BE , Cangtemi D, Vazquez-Roque M. bloating: mechanisms and management Clin Gastroenterol Hepatol. 2021; 19:21-231.
  • Werlang M, Farraye F, Lacy BE . Eating disorders and inflammatory bowel disease Inflamm Bowel Dis 2021. 2021.
  • Lacy BE , Shea EP, Manuel M, Abel JL, Jiang H, Taylor DCA. Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. PLoS One. 2021; 16 (1):e0243318 Epub 2021 Jan 11 View PubMed
  • Werlang ME, Sim LA, Lebow JR, Lacy BE . Assessing for Eating Disorders: A Primer for Gastroenterologists. Am J Gastroenterol. 2021 Jan 1; 116 (1):68-76 View PubMed
  • Chris-Olaiya A, Palmer W, Stancampiano F, Lacy B , Heckman M, Chirila R, Nikpour N, Mcleod E, Ryan T, Maillis A, Vargas E, Bouras E. Medication use and polypharmacy in patients referred to a tertiary gastroenterology practice. Rom J Intern Med. 2020 Dec 1; 58 (4):228-232 Epub 2020 Dec 17 View PubMed
  • Lacy BE . Update on Irritable Bowel Syndrome Guidelines. Gastroenterol Hepatol (N Y). 2020 Dec; 16 (12):648-650 View PubMed
  • Ford AC, Mahadeva S, Carbone MF, Lacy BE , Talley NJ. Functional dyspepsia. Lancet. 2020 Nov 21; 396(10263):1689-1702. Epub 2020 Oct 10. View PubMed
  • Cangemi DJ, Lacy BE . Gastroparesis and functional dyspepsia: different diseases or different ends of the spectrum? Curr Opin Gastroenterol. 2020 Nov; 36 (6):509-517 View PubMed
  • Miller AT, Matar R, Abu Dayyeh BK, Beran A, Vela MF, Lacy BE , Crowell MD, Geno DM, Lavey CJ, Katzka DA, Ravi K. Postobesity Surgery Esophageal Dysfunction: A Combined Cross-Sectional Prevalence Study and Retrospective Analysis. Am J Gastroenterol. 2020 Oct; 115 (10):1669-1680 View PubMed
  • Lacy BE . An Individualized, Case-Based Approach to the Management of Irritable Bowel Syndrome. J Fam Pract. 2020 Sep; 69 (7 Suppl):S8-S13 View PubMed
  • Bharucha AE, Lacy BE . Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology. 2020 Apr; 158 (5):1232-1249.e3 Epub 2020 Jan 13 View PubMed
  • Lacy BE , Cangemi DJ. Making the diagnosis of functional dyspepsia Gastroenterol Rev LatAm in press. 2020.
  • Lacy BE . Patient-Centric Care of Diarrhea-Predominant Irritable Bowel Syndrome. J Fam Pract. 2019 Oct; 68 (8):S43-S48 View PubMed
  • Kroner PT, Tolaymat OA, Bowman AW, Abril A, Lacy BE . Gastrointestinal Manifestations of Rheumatological Diseases. Am J Gastroenterol. 2019 Sep; 114 (9):1441-1454 View PubMed
  • Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE , Vela MF. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose. Am J Gastroenterol. 2019 Sep; 114 (9):1464-1469 View PubMed
  • Cash BD, Lacy BE , Schoenfeld PS, Dove LS, Covington PS. Response to Lai. Am J Gastroenterol 2019 Jul; 114 (7):1177-1178 View PubMed
  • Lacy BE , Spiegel B. Introduction to the Gut Microbiome Special Issue. Am J Gastroenterol 2019 Jul; 114 (7):1013 View PubMed
  • Lacy BE , Everhart K, Crowell MD. Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores. Dig Dis Sci. 2019 May; 64 (5):1281-1287 Epub 2018 Oct 31 View PubMed
  • Chey WD, Lacy BE , Cash BD, Epstein M, Corsino PE, Shah SM. A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial. Clin Transl Gastroenterol. 2019 Apr; 10 (4):e00021 View PubMed
  • Lacy BE . Update on the management of chronic idiopathic constipation. Am J Manag Care. 2019 Mar; 25 (4 Suppl):S55-S62 View PubMed
  • Navas CM, Crowell MD, Lacy BE . The willingness of patients with gastroparesis to take risks with medications. Aliment Pharmacol Ther. 2019 Feb; 49(4):429-436. Epub 2019 Jan 09. View PubMed
  • Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Lacy BE , Andrews CN, Leontiadis GI, Moayyedi P. Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials. Am J Gastroenterol. 2019 Feb; 114 (2):233-243 View PubMed
  • Werlang ME, Palmer WC, Lacy BE . Irritable Bowel Syndrome and Dietary Interventions. Gastroenterol Hepatol (N Y). 2019 Jan; 15 (1):16-26 View PubMed
  • Lacy B , Ayyagari R, Guerin A, Lopez A, Shi S, Luo M. Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome. Therap Adv Gastroenterol. 2019; 12:1756284818818326 Epub 2019 Jan 01 View PubMed
  • Lacy BE , Harris LA, Chang L, Lucak S, Gutman C, Dove LS, Covington PS, Lembo A. Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials. Therap Adv Gastroenterol. 2019; 12:1756284819841290 Epub 2019 Apr 15 View PubMed
  • Navas CM, Patel NK, Lacy BE . Symptomatic Management of Gastroparesis. Gastrointest Endosc Clin N Am. 2019 Jan; 29 (1):55-70 Epub 2018 Sept 11 View PubMed
  • Lacy BE , Crowell MD, Camilleri M. The Challenges of Gastroparesis: Changing Study Design to Improve Clinical Care. Am J Gastroenterol. 2019 Jan; 114 (1):1-3 View PubMed
  • Ford AC, Lacy BE , Harris LA, Quigley EMM, Moayyedi P. Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019 Jan; 114 (1):21-39 View PubMed
  • Cangemi DJ, Lacy BE . Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions. Therap Adv Gastroenterol. 2019; 12:1756284819878950 Epub 2019 Oct 04 View PubMed
  • Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE , Vela MF. Effect of Opiod type and dosing on opioid induced esophageal dysfunction (OIED) AM J Gastroenterol. 2019; 114:1464-1469.
  • Lacy BE , Spiegel B. Introduction to the 80% by 2018 Special Issue. Am J Gastroenterol 2018 Dec; 113 (12):1737-1738 Epub 2018 Oct 30 View PubMed
  • Ford AC, Harris LA, Lacy BE , Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018 Nov; 48 (10):1044-1060 Epub 2018 Oct 08 View PubMed
  • Lacy BE . Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2018 Oct; 48 (8):817-830 Epub 2018 Sept 07 View PubMed
  • Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE , Saito YA, Quigley EMM, Moayyedi P. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol. 2018 Sep; 113 (9):1290-1300 Epub 2018 July 26 View PubMed
  • Lacy BE . Practical Evaluation and Management of Irritable Bowel Syndrome with Diarrhea: A Case Study Approach. J Fam Pract. 2018 Aug; 67 (8 suppl):S31-S36 View PubMed
  • Yadlapati R, Vaezi MF, Vela MF, Spechler SJ, Shaheen NJ, Richter J, Lacy BE , Katzka D, Katz PO, Kahrilas PJ, Gyawali PC, Gerson L, Fass R, Castell DO, Craft J, Hillman L, Pandolfino JE. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018 Jul; 113 (7):980-986 Epub 2018 Apr 24 View PubMed
  • Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE , Saito YA, Quigley EMM, ACG Task Force on Management of Irritable Bowel Syndrome. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2018 Jun; 113 (Suppl 2):1-18 View PubMed
  • Lacy BE , Nicandro JP, Chuang E, Earnest DL. A prospective, multi center study of alosteron use in clinical practice: significant improvement in IBS symtpoms using the FDA composite endpoint Therapeutic ADV Gastroenterol. 2018.
  • Lacy BE , Parkman HP, Camilleri M. Chronic nausea and vomiting: evaluation and treatment. Am J Gastroenterol. 2018 May; 113 (5):647-659 Epub 2018 Mar 15 View PubMed
  • Lacy BE , Chan JL. Physician Burnout: The Hidden Health Care Crisis. Clin Gastroenterol Hepatol. 2018 Mar; 16(3):311-317. Epub 2017 Jun 30. View PubMed
  • Lacy BE , Ford AC, Talley NJ. Quality of Care and the Irritable Bowel Syndrome: Is Now the Time to Set Standards? Am J Gastroenterol. 2018 Feb; 113 (2):167-169 Epub 2017 Dec 05 View PubMed
  • Lacy BE , Saito YA, Camilleri M, Bouras E, DiBaise JK, Herrick LM, Szarka LA, Tilkes K, Zinsmeister AR, Talley NJ. Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia. Am J Gastroenterol. 2018 Feb; 113 (2):216-224 Epub 2017 Dec 19 View PubMed
  • Lacy BE , Crowell MD, Mathis C, Bauer D, Heinberg LJ. Gastroparesis: Quality of Life and Health Care Utilization. J Clin Gastroenterol. 2018 Jan; 52 (1):20-24 View PubMed
  • Taylor F, Higgins S, Carson RT, Eremenco S, Foley C, Lacy BE , Parkman HP, Reasner DS, Shields AL, Tack J, Talley NJ. Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD). Am J Gastroenterol. 2018 Jan; 113 (1):39-48 Epub 2017 Sept 19 View PubMed
  • Schoenfeld P, Lacy BE , Chey WD, Lembo AJ, Kurtz CB, Reasner DS, Bochenek W, Tripp K, Currie MG, Fox SM, Blakesley RE, O'Dea CR, Omniewski ND, Hall ML. Low-Dose Linaclotide (72 mug) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Am J Gastroenterol. 2018 Jan; 113 (1):105-114 Epub 2017 Aug 22 View PubMed
  • Lacy BE , Nicandro JP, Chuang E, Earnest DL. Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint. Therap Adv Gastroenterol. 2018; 11:1756284818771674 Epub 2018 May 08 View PubMed
  • Lacy BE , Crowell MD, Mathis C, Bauer D, Heinberg LJ. American College of Gastroenterolgy and Canadian Association of Gastroenterology guidelines onn the management of dyspepsia J Clin Gastroenterol. 2018; 52:20-24.
  • Yadlapati R, Keswani RN, Ciolino JD, Grande DP, Listernick ZI, Carlson DA, Castell DO, Dunbar KB, Gawron AJ, Gyawali CP, Katz PO, Katzka D, Lacy BE , Spechler SJ, Tatum R, Vela MF, Pandolfino JE. A System to Assess the Competency for Interpretation of Esophageal Manometry Identifies Variation in Learning Curves. Clin Gastroenterol Hepatol. 2017 Nov; 15 (11):1708-1714.e3 Epub 2016 July 27 View PubMed
  • Lacy BE , Spiegel B. No Results? No Problem! Why We Are Publishing Methods of a Landmark Study With Results Still Pending. Am J Gastroenterol. 2017 Nov; 112 (11):1747-1748 View PubMed
  • Lacy BE , Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017 Oct 26; 6 (11) View PubMed
  • Cash BD, Lacy BE , Schoenfeld PS, Dove LS, Covington PS. Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder. Am J Gastroenterol. 2017 Oct; 112 (10):1619-1620 View PubMed
  • Cash BD, Lacy BE , Schoenfeld PS, Dove LS, Covington PS. Response to Croteau and Barkin. Am J Gastroenterol. 2017 Oct; 112 (10):1617 View PubMed
  • Navas CM, Patel NK, Lacy BE . Gastroparesis: Medical and Therapeutic Advances. Dig Dis Sci. 2017 Sep; 62 (9):2231-2240 Epub 2017 July 18 View PubMed
  • Moayyedi PM, Lacy BE , Andrews CN, Enns RA, Howden CW, Vakil N. Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017 Sep; 112 (9):1484 Epub 2017 Aug 01 View PubMed
  • Lacy BE , Chey WD, Cash BD, Lembo AJ, Dove LS, Covington PS. Corrigendum: Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. Am J Gastroenterol. 2017 Jul; 112 (7):1210 Epub 2017 May 30 View PubMed
  • Moayyedi PM, Lacy BE , Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017 Jul; 112 (7):988-1013 Epub 2017 June 20 View PubMed
  • Ford AC, Lacy BE , Talley NJ. Irritable Bowel Syndrome. N Engl J Med. 2017 Jun 29; 376 (26):2566-2578 View PubMed
  • Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE , DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ. Polymorphisms of 5-HTT LPR and GNß3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol. 2017 Jun; 112(6):903-909. Epub 2017 Mar 14. View PubMed
  • Lacy BE , Chey WD, Cash BD, Lembo AJ, Dove LS, Covington PS. Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. Am J Gastroenterol. 2017 Jun; 112 (6):924-932 Epub 2017 Apr 18 View PubMed
  • Lacy BE . Hot Topics in Primary Care: Role of the Microbiome in Disease: Implications for Treatment of Irritable Bowel Syndrome. J Fam Pract. 2017 Apr; 66 (4 Suppl):S40-S45 View PubMed
  • Koliani-Pace J, Lacy BE . Update on the Management of Chronic Constipation. Curr Treat Options Gastroenterol. 2017 Mar; 15 (1):126-134 View PubMed
  • Crowell MD, Umar SB, Griffing WL, DiBaise JK, Lacy BE , Vela MF. Esophageal Motor Abnormalities in Patients With Scleroderma: Heterogeneity, Risk Factors, and Effects on Quality of Life. Clin Gastroenterol Hepatol. 2017 Feb; 15 (2):207-213.e1 Epub 2016 Sept 06 View PubMed
  • Cash BD, Lacy BE , Schoenfeld PS, Dove LS, Covington PS. Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. Am J Gastroenterol. 2017 Feb; 112 (2):365-374 Epub 2016 Dec 06 View PubMed
  • Putra J, Muller KE, Hussain ZH, Parker S, Gabbard S, Brickley EB, Lacy BE , Rothstein R, Lisovsky M. Lymphocytic Esophagitis in Nonachalasia Primary Esophageal Motility Disorders: Improved Criteria, Prevalence, Strength of Association, and Natural History. Am J Surg Pathol. 2016 Dec; 40 (12):1679-1685 View PubMed
  • Shah SL, Lacy BE . Dietary Interventions and Irritable Bowel Syndrome: A Review of the Evidence. Curr Gastroenterol Rep. 2016 Aug; 18 (8):41 View PubMed
  • Lacy BE , Moreau JC. Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations. J Am Assoc Nurse Pract. 2016 Jul; 28 (7):393-404 View PubMed
  • Lacy BE . Perspective: An easier diagnosis. Nature. 2016 May 19; 533 (7603):S107 View PubMed
  • Lacy BE . Effects of Opioids on Esophageal Dysfunction. Gastroenterol Hepatol (N Y). 2016 May; 12 (5):323-5 View PubMed
  • Yadlapati R, Gawron AJ, Keswani RN, Bilimoria K, Castell DO, Dunbar KB, Gyawali CP, Jobe BA, Katz PO, Katzka DA, Lacy BE , Massey BT, Richter JE, Schnoll-Sussman F, Spechler SJ, Tatum R, Vela MF, Pandolfino JE. Identification of Quality Measures for Performance of and Interpretation of Data From Esophageal Manometry. Clin Gastroenterol Hepatol. 2016 Apr; 14 (4):526-534.e1 Epub 2015 Oct 20 View PubMed
  • Levenick JM, Gordon SR, Fadden LL, Levy LC, Rockacy MJ, Hyder SM, Lacy BE , Bensen SP, Parr DD, Gardner TB. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients. Gastroenterology. 2016 Apr; 150 (4):911-7; quiz e19 Epub 2016 Jan 09 View PubMed
  • Mearin F, Lacy BE , Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016 Feb 18 [Epub ahead of print] View PubMed
  • Lembo AJ, Lacy BE , Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS. Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med. 2016 Jan 21; 374 (3):242-53 View PubMed
  • Lacy BE , Patel H, Guerin A, Dea K, Scopel JL, Alaghband R, Wu EQ, Mody R. Variation in Care for Patients with Irritable Bowel Syndrome in the United States. PLoS One. 2016; 11 (4):e0154258 Epub 2016 Apr 26 View PubMed
  • Cash BD, Lacy BE , Rao T, Earnest DL. Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron? Expert Opin Pharmacother. 2016; 17(3):311-22. Epub 2015 Dec 08. View PubMed
  • Lacy BE , Spiegel B. The American Journal of Gastroenterology in 2016: Where Have We Been? Where Are We Going? Am J Gastroenterol. 2016 Jan; 111 (1):1-3 Epub 2016 Jan 12 View PubMed
  • Lacy BE . Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016; 9:7-17 Epub 2016 Feb 11 View PubMed
  • Lacy BE . Eluxadoline: A novel treament for diarrhea predominant IBS Neurogastroenterol Motil. 2016; 28:26-35.
  • Lacy BE . Neuroenteric Stimulation for Gastroparesis. Curr Treat Options Gastroenterol. 2015 Dec; 13 (4):409-17 View PubMed
  • Shah SL, Lacy BE , DiBaise JK, Vela MF, Crowell MD. The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy. Aliment Pharmacol Ther. 2015 Nov; 42(9):1093-100. Epub 2015 Sep 08. View PubMed
  • Lacy BE . The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2015 Nov; 13 (11):1899-906 Epub 2015 Mar 10 View PubMed
  • Xue Y, Suriawinata A, Liu X, Li Z, Gabbard S, Rothstein R, Lacy B , Lisovsky M. Lymphocytic Esophagitis With CD4 T-cell-predominant Intraepithelial Lymphocytes and Primary Esophageal Motility Abnormalities: A Potential Novel Clinicopathologic Entity. Am J Surg Pathol. 2015 Nov; 39 (11):1558-67 View PubMed
  • Hussain ZH, Henderson EE, Maradey-Romerao C, George N, Fass R, Lacy BE . The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol. 2015 Oct 8; 6:e115 Epub 2015 Oct 08 View PubMed
  • Moayyedi P, Quigley EM, Lacy BE , Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Ford AC. The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review. Clin Transl Gastroenterol. 2015 Aug 20; 6 (8):e107 View PubMed
  • Hussain ZH, Henderson EE, Maradey-Romerao C, George N, Fass R, Lacy BE . The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol. 2015 Aug 13; 6:e106 View PubMed
  • Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE , DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015 Aug; 149 (2):340-9.e2 Epub 2015 Apr 25 View PubMed
  • Crowell MD, Umar SB, Lacy BE , Jones MP, DiBaise JK, Talley NJ. Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci. 2015 Aug; 60 (8):2270-9 Epub 2015 Apr 05 View PubMed
  • Stein B, Everhart KK, Lacy BE . Gastroparesis: A Review of Current Diagnosis and Treatment Options. J Clin Gastroenterol. 2015 Aug; 49 (7):550-8 View PubMed
  • Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, Lacy BE , Murray JA. Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids. Am J Gastroenterol. 2015 Jul; 110 (7):979-84 Epub 2015 June 02 View PubMed
  • Lacy BE . Proton Pump Inhibitor Nonresponders. Gastroenterol Hepatol (N Y). 2015 Jul; 11 (7):483-5 View PubMed
  • Lacy BE , Chey WD, Lembo AJ. New and Emerging Treatment Options for Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y). 2015 Apr; 11 (4 Suppl 2):1-19 View PubMed
  • Hussain ZH, Everhart K, Lacy BE . Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies. Gastroenterol Hepatol (N Y). 2015 Feb; 11 (2):104-14 View PubMed
  • Lacy BE , Yu J, Crowell MD. Medication risk-taking behavior in functional dyspepsia patients. Clin Transl Gastroenterol. 2015 Jan 8; 6:e69 Epub 2015 Jan 08 View PubMed
  • Lacy BE , Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X, Cronin JA, Currie MG, Kurtz CB, Johnston JM, Lembo AJ. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial. PLoS One. 2015; 10 (7):e0134349 Epub 2015 July 29 View PubMed
  • Hussain Z, Lacy BE , Fass R. The PPI non responder Clin Transl Gastroenterol. 2015; 106.
  • Stein B, Everhart KK, Lacy BE . Treatment of functional dyspepsia and gastroparesis. Curr Treat Options Gastroenterol. 2014 Dec; 12 (4):385-97 View PubMed
  • Lacy BE , O'Shana T. Clinical pearls for irritable bowel syndrome: management of the diarrhea-predominant subtype. Gastroenterol Nurs. 2014 Nov-Dec; 37 (6):392-405 View PubMed
  • Ford AC, Quigley EM, Lacy BE , Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014 Oct; 109 (10):1547-61; quiz 1546, 1562 Epub 2014 July 29 View PubMed
  • Moayyedi P, Quigley EM, Lacy BE , Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Ford AC. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2014 Sep; 109 (9):1367-74 Epub 2014 July 29 View PubMed
  • Ford AC, Quigley EM, Lacy BE , Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014 Sep; 109 (9):1350-65; quiz 1366 Epub 2014 June 17 View PubMed
  • Hussain ZH, Whitehead DA, Lacy BE . Fecal impaction. Curr Gastroenterol Rep. 2014 Sep; 16 (9):404 View PubMed
  • Ford AC, Moayyedi P, Lacy BE , Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Quigley EM, Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014 Aug; 109 Suppl 1:S2-26; quiz S27 View PubMed
  • Ratuapli SK, Hansel SL, Umar SB, Burdick GE, Ramirez FC, Fleischer DE, Harris LA, Lacy BE , DiBaise JK, Crowell MD. Esophageal peristaltic defects in adults with functional dysphagia. Dysphagia. 2014 Aug; 29 (4):519-26 Epub 2014 June 04 View PubMed
  • Lacy BE , Hussain ZH, Mearin F. Treatment for constipation: new and old pharmacological strategies. Neurogastroenterol Motil. 2014 Jun; 26 (6):749-63 View PubMed
  • Gabbard SL, Lacy BE , Levine GM, Crowell MD. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci. 2014 Mar; 59 (3):638-44 Epub 2013 Dec 10 View PubMed
  • Lacy BE , Lembo AJ, Macdougall JE, Shiff SJ, Kurtz CB, Currie MG, Johnston JM. Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C. Neurogastroenterol Motil. 2014 Mar; 26(3):326-33. Epub 2013 Dec 30. View PubMed
  • Lacy BE , Chey WD, Chang L. An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D. Gastroenterol Hepatol (N Y). 2013 Nov; 9 (11 Suppl 5):1-24 View PubMed
  • Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, DeVault K, Fass R, Gyawali CP, Kahrilas PJ, Lacy BE , Pandolfino JE, Patti MG, Swanstrom LL, Kurian AA, Vela MF, Vaezi M, DeMeester TR. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg 2013 Oct; 217 (4):586-97 Epub 2013 Aug 21 View PubMed
  • Lacy BE , Wang F, Bhowal S, Schaefer E, study group. On-demand hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain. Scand J Gastroenterol. 2013 Aug; 48 (8):926-35 View PubMed
  • Lacy BE , Weiser KT, Kennedy AT, Crowell MD, Talley NJ. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013 Jul; 38(2):170-7. Epub 2013 Jun 03. View PubMed
  • Gabbard SL, Lacy BE . Chronic intestinal pseudo-obstruction. Nutr Clin Pract. 2013 Jun; 28 (3):307-16 Epub 2013 Apr 23 View PubMed
  • Quigley EM, Lacy BE . Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol. 2013 Mar; 10 (3):175-86 Epub 2013 Jan 08 View PubMed
  • Lacy BE . Functional dyspepsia and gastroparesis: one disease or two? Am J Gastroenterol. 2012 Nov; 107 (11):1615-20 View PubMed
  • Lacy BE , Levenick JM, Crowell MD. Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome. Gastroenterol Hepatol (N Y). 2012 Oct; 8 (10):653-60 View PubMed
  • Mearin F, Lacy BE . Diagnostic criteria in IBS: useful or not? Neurogastroenterol Motil. 2012 Sep; 24(9):791-801. View PubMed
  • Lacy BE , Levenick J, Crowell M. Recent advances in the management of difficult constipation. Curr Gastroenterol Rep. 2012 Aug; 14 (4):306-12 View PubMed
  • Lacy BE , Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15. Epub 2012 May 16. View PubMed
  • Lacy BE , Levenick JM, Crowell M. Chronic constipation: new diagnostic and treatment approaches. Therap Adv Gastroenterol. 2012 Jul; 5 (4):233-47 View PubMed
  • Lacy BE , Everhart KK, Weiser KT, DeLee R, Strobel S, Siegel C, Crowell MD. IBS patients' willingness to take risks with medications. Am J Gastroenterol. 2012 Jun; 107 (6):804-9 View PubMed
  • Ratuapli SK, Ellington TG, O'Neill MT, Umar SB, Harris LA, Foxx-Orenstein AE, Burdick GE, Dibaise JK, Lacy BE , Crowell MD. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012 May; 107 (5):730-5 Epub 2012 Feb 14 View PubMed
  • Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE , DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33. Epub 2012 Feb 10. View PubMed
  • Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE , Müller-Lissner S, Quigley EM, Schuurkes J, De Maeyer JH, Stanghellini V. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr; 35(7):745-67. Epub 2012 Feb 22. View PubMed
  • Lacy BE . Technical review: Utilization of pH monitoring technologies. Consensus statement from the Esophageal Diagnostic working Group Dis Esophagus. 2012.
  • Lacy BE , Gabbard SL, Crowell MD. Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air? Gastroenterol Hepatol (N Y). 2011 Nov; 7 (11):729-39 View PubMed
  • Lacy BE , Chehade R, Crowell MD. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11). Am J Gastroenterol. 2011 Sep; 106 (9):1604-11 Epub 2011 June 21 View PubMed
  • Lacy BE , Carter J, Weiss JE, Crowell MD. The effects of intraduodenal nutrient infusion on serum CCK, LES pressure, and gastroesophageal reflux. Neurogastroenterol Motil. 2011 Jul; 23(7):631-e256. Epub 2011 Mar 21. View PubMed
  • Lacy BE , Dukowicz AC, Robertson DJ, Weiss JE, Teixeira P, Kelley ML Jr. Clinical utility of the wireless pH capsule. J Clin Gastroenterol. 2011 May-Jun; 45 (5):429-35 View PubMed
  • Lacy BE , Everhart K, Crowell MD. Functional dyspepsia is associated with sleep disorders. Clin Gastroenterol Hepatol. 2011 May; 9 (5):410-4 Epub 2011 Feb 17 View PubMed
  • Lacy BE , Dukowicz AC, Robertson DJ, Weiss JE, Kelley MLK. Clinical utility of the Bravo pH capsule Clin Gastroenterol. 2011; 45:429-435.
  • Lacy BE . IBS Treatment: What's in the pipeline? Gastroenterol Hepatol. 2011.
  • Lacy BE , Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105 (12):2525-9 View PubMed
  • Chang L, Lacy BE , Spiegel BM. An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium. Gastroenterol Hepatol (N Y). 2010 Sep; 6 (9 Suppl 15):1-12 View PubMed
  • Lacy BE , Weiser K, Chertoff J, Fass R, Pandolfino JE, Richter JE, Rothstein RI, Spangler C, Vaezi MF. The diagnosis of gastroesophageal reflux disease. Am J Med. 2010 Jul; 123 (7):583-92 Epub 2010 May 20 View PubMed
  • Gardner TB, Kennedy AT, Gelrud A, Banks PA, Vege SS, Gordon SR, Lacy BE . Chronic pancreatitis and its effect on employment and health care experience: results of a prospective American multicenter study. Pancreas. 2010 May; 39 (4):498-501 View PubMed
  • Lacy BE , Loew B, Crowell MD. Prucalopride for chronic constipation. Drugs Today (Barc). 2009 Dec; 45(12):843-53. View PubMed
  • Kennedy AT, Weiser KT, Crowell MD, Talley NJ, Lacy BE . Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol. 2009 Nov-Dec; 43 (10):933-40 View PubMed
  • Lacy BE , Paquette L, Robertson DJ, Kelley ML Jr, Weiss JE. The clinical utility of esophageal manometry. J Clin Gastroenterol. 2009 Oct; 43 (9):809-15 View PubMed
  • Lacy BE , Weiser K. Common anorectal disorders: diagnosis and treatment. Curr Gastroenterol Rep. 2009 Oct; 11(5):413-9. View PubMed
  • Lacy Be , Loew B. chronic intestinal pseudo obstruction Pract Gastroenterol. 2009; 9-24.
  • Lacy BE , Edwards S, Paquette L, Weiss J, Kelley ML Jr, Ornvold K. Tolerability and clinical utility of the Bravo pH capsule in children. J Clin Gastroenterol. 2009 Jul; 43 (6):514-9 View PubMed
  • Lacy BE , Weiser K, De Lee R. The treatment of irritable bowel syndrome. Therap Adv Gastroenterol. 2009 Jul; 2 (4):221-38 View PubMed
  • Lacy BE , Chey WD. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation. Expert Opin Pharmacother. 2009 Jan; 10 (1):143-52 View PubMed
  • Lacy BE . A practical guide to irritable bowel syndrome-Alosetron HC1 (Lotronex)-Risk Gastroenterol Hepatolo Rev 2009. 2009; 5:62-67.
  • Lacy BE , Mathis C, DesBiens J, Liu MC. The effects of nebulized albuterol on esophageal function in asthmatic patients. Dig Dis Sci. 2008 Oct; 53(10):2627-33. Epub 2008 Feb 13. View PubMed
  • Lacy BE , Weiser K. Esophageal motility disorders: medical therapy. J Clin Gastroenterol. 2008 May-Jun; 42(5):652-8. View PubMed
  • Lee WC, Yeh YC, Lacy BE , Pandolfino JE, Brill JV, Weinstein ML, Carlson AM, Williams MJ, Wittek MR, Pashos CL. Timely confirmation of gastro-esophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations. Curr Med Res Opin. 2008 May; 24(5):1317-27. Epub 2008 Mar 27. View PubMed
  • Lacy BE , Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future? Gastroenterol Hepatol (N Y). 2008 Apr; 4 (4):283-95 View PubMed
  • Lacy BE , Cash BD. A 32-year-old woman with chronic abdominal pain. JAMA. 2008 Feb 6; 299 (5):555-65 Epub 2008 Jan 01 View PubMed
  • Lacy BE , Levy LC. Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging. 2008; 3 (2):357-64 View PubMed
  • Weiser KT, Lacy BE , Noddin L, Crowell MD. Patient knowledge and perspective on irritable bowel syndrome: development of a survey instrument. Dig Dis Sci. 2008 Jan; 53(1):284-95. Epub 2007 Jun 28. View PubMed
  • Crowell MD, Schettler VA, Lacy BE , Lunsford TN, Harris LA, DiBaise JK, Jones MP. Impact of anal incontinence on psychosocial function and health-related quality of life. Dig Dis Sci. 2007 Jul; 52 (7):1627-31 Epub 2007 Jan 09 View PubMed
  • Lacy BE , Weiser K, Noddin L, Robertson DJ, Crowell MD, Parratt-Engstrom C, Grau MV. Irritable bowel syndrome: patients' attitudes, concerns and level of knowledge. Aliment Pharmacol Ther. 2007 Jun 01; 25(11):1329-41. View PubMed
  • Lacy BE , Levy LC. Lubiprostone: a chloride channel activator. J Clin Gastroenterol. 2007 Apr; 41(4):345-51. View PubMed
  • Dukowicz AC, Lacy BE , Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007 Feb; 3 (2):112-22 View PubMed
  • Lacy BE , O'Shana T, Hynes M, Kelley ML Jr, Weiss JE, Paquette L, Rothstein RI. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol. 2007 Jan; 102 (1):24-32 Epub 2006 Nov 13 View PubMed
  • Cash BD, Lacy BE . Systematic Review: FDA-Approved Prescription Medications for Adults With Constipation. Gastroenterol Hepatol (N Y). 2006 Oct; 2 (10):736-749 View PubMed
  • Lacy BE , Rosemore J, Robertson D, Corbin DA, Grau M, Crowell MD. Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome. Scand J Gastroenterol. 2006 Aug; 41 (8):892-902 View PubMed
  • Lacy BE . Lubiprostone for Chronic Constipation. Gastroenterol Hepatol (N Y). 2006 Jul; 2 (7):483 View PubMed
  • Lacy BE , Weiser K. Gastrointestinal motility disorders: an update. Dig Dis. 2006; 24 (3-4):228-42 View PubMed
  • Lacy BE , Weiser K. Gastric motility, gastroparesis, and gastric stimulation. Surg Clin North Am. 2005 Oct; 85 (5):967-87, vi-vii View PubMed
  • Crowell MD, Mathis C, Schettler VA, Yunus T, Lacy BE . The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus. Neurogastroenterol Motil. 2005 Oct; 17 (5):738-43 View PubMed
  • Noddin L, Callahan M, Lacy BE . Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations? MedGenMed. 2005 Aug 29; 7 (3):17 View PubMed
  • Ali MA, Lacy BE . Esophageal manometry and pH monitoring: gastroenterologists' adherence to published guidelines. J Clin Gastroenterol. 2005 Aug; 39 (7):584-90 View PubMed
  • Lacy BE , Crowell MD, Riesett RP, Mitchell A. Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior. J Clin Gastroenterol. 2005 Jul; 39 (6):489-94 View PubMed
  • Lacy BE , Lee RD. Irritable bowel syndrome: a syndrome in evolution. J Clin Gastroenterol. 2005 May-Jun; 39 (5 Suppl 3):S230-42 View PubMed
  • Lacy BE , Brunton SA. Partnering with gastroenterologists to evaluate patients with chronic constipation. MedGenMed. 2005 Apr 28; 7 (2):19 View PubMed
  • lacy BE . Clinial Advances in Upper GI functional Disorders Medscape General Medicine. 2005.
  • Crowell MD, Lacy BE , Schettler VA, Dineen TN, Olden KW, Talley NJ. Subtypes of anal incontinence associated with bowel dysfunction: clinical, physiologic, and psychosocial characterization. Dis Colon Rectum. 2004 Oct; 47 (10):1627-35 View PubMed
  • Lacy BE , Crowell MD, Schettler-Duncan A, Mathis C, Pasricha PJ. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care. 2004 Oct; 27(10):2341-7. View PubMed
  • Rosemore J, Nikoomanesh P, Lacy BE . Bilateral temporomandibular joint dislocation after PEG tube placement. Gastrointest Endosc. 2004 Jan; 59(1):146-7. View PubMed
  • Lacy BE , Cole MS. constipation in the older adult Clinical Geriatrics. 2004; 12:44-54.
  • Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE , Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003 Nov; 98 (11):2454-9 View PubMed
  • Lacy BE . Irritable bowel syndrome: a primer on management. Rev Gastroenterol Disord. 2003; 3 Suppl 3:S32-42. View PubMed
  • Lacy Be . Irritable bowel syndrome - An update for primary care physicians Rev Internal Medicine. 2003.
  • Lacy BE , Zayat EN, Crowell MD. Case report: botulinum toxin in hypertensive lower esophageal sphincter: a manometric case study. Dysphagia. 2002 Winter; 17 (1):75-80 View PubMed
  • Rosemore JG, Lacy BE . Irritable bowel syndrome: basis of clinical management strategies. J Clin Gastroenterol. 2002 Jul; 35 (1 Suppl):S37-44 View PubMed
  • Lacy BE , Zayat EN, Crowell MD, Schuster MM. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol. 2002 Jun; 97 (6):1548-52 View PubMed
  • Moncur JT, Lacy BE , Longnecker DS. Mixed acinar-endocrine carcinoma arising in the ampulla of Vater. Hum Pathol. 2002 Apr; 33(4):449-51. View PubMed
  • Pope GD, Goodney PP, Burchard KW, Proia RR, Olafsson A, Lacy BE , Burrows LJ. Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg. 2002 Feb; 12 (1):30-3 View PubMed
  • Fuss IJ, Boirivant M, Lacy B , Strober W. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol. 2002 Jan 15; 168 (2):900-8 View PubMed
  • Lacy BE , Yu S. Tegaserod: a new 5-HT4 agonist. J Clin Gastroenterol. 2002 Jan; 34(1):27-33. View PubMed
  • Pande H, Lacy BE , Crowell MD. Inflammatory causes of gastroparesis Dig Dis Sci. 2002; 47:2664-2668.
  • Byrnes CK, Nass PH, Shim J, Duncan MD, Lacy B , Harmon JW. Novel nuclear shuttle peptide to increase transfection efficiency in esophageal mucosal cells. J Gastrointest Surg. 2002 Jan-Feb; 6 (1):37-42 View PubMed
  • Lacy Be . Tegaserod Clinical Perspectives in Gastroenterology. 2002; 5:251-255.
  • Crowell MD, Zayat EN, Lacy BE , Schettler-Duncan A, Liu MC. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest. 2001 Oct; 120(4):1184-9. View PubMed
  • Lacy BE , Rosemore J. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr. 2001 Oct; 131 (10):2789S-2793S View PubMed
  • Lacy BE , Zayat E, Crowell MD. Generalized intestinal dysmotility in a patient with syringomyelia. Am J Gastroenterol. 2001 Apr; 96 (4):1282-5 View PubMed
  • Mussa FF, Younes Z, Tihan T, Lacy BE . Anasarca and small bowel obstruction secondary to endometriosis. J Clin Gastroenterol. 2001 Feb; 32 (2):167-71 View PubMed
  • Lacy BE , Toor A, Bensen SP, Rothstein RI, Maheshwari Y. Acute esophageal necrosis: report of two cases and a review of the literature. Gastrointest Endosc. 1999 Apr; 49 (4 Pt 1):527-32 View PubMed
  • Fox BS, Dordai D, Moore RL, Lacy BE . In vivo priming of helper T cells in the absence of B cell activation. J Immunol. 1989 Dec 15; 143 (12):3887-93 View PubMed
  • Lacy BE , Underhill CB. The hyaluronate receptor is associated with actin filaments. J Cell Biol. 1987 Sep; 105 (3):1395-404 View PubMed
  • Lacy BE , Underhill CB. A protein binding assay for hyaluronate. Anal Biochem. 1986 Nov 1; 158 (2):436-42 View PubMed
  • Lacy BE . Neural crest cell migration and the extracellular matrix J. Wash. Acad.Sci. 1983; 73:128-140.

One gift, 3X the impact

Join our Year-End Challenge and triple your gift to help shape the future of healthcare!

brian e. lacy md phd jacksonville

  • Meet Our Team
  • Press Coverage
  • VRx the Book
  • Patient Videos

brian e. lacy md phd jacksonville

  • About vMed24
  • Demo at vMed
  • Apply to Speak
  • Apply to Present Abstract
  • Apply for a Press Pass
  • Reserve Hotel Room at Sofitel
  • Apply for Patient Waiver
  • Apply for CTSI Student Ticket
  • Conferences
  • » vMed23 Conference Presentations
  • » vMed22 Conference Presentations
  • » vMed19 Conference Presentations
  • » vMed18 Conference Presentations
  • » vMed Photo Gallery
  • Hands-On Clinical Training
  • Our Published Research
  • Our Current Trials
  • App Development
  • For Clinicians
  • Our Favorite VR Programs
  • VR Clinical Care
  • Find a VR Provider
  • Meet the Team

brian e. lacy md phd jacksonville

  • vMed24 Conference
  • Education & Training
  • » 2019 Conference Presentations
  • » 2018 Conference Presentations
  • » Photo Gallery
  • Research & Development
  • Our Research
  • Clinical Care

brian e. lacy md phd jacksonville

Brian Lacy, MD, PhD Mayo Clinic

Brian E. Lacy, Ph.D., M.D., FACG is currently Professor of Medicine and Consultant at Mayo Clinic Jacksonville. He is the Program Director of the GI Fellowship, and is Associate Program Director for Scholarly Activities for the Medical Residency Program. He previously worked at the Dartmouth-Hitchcock Medical Center where he was Section Chief of Gastroenterology and Hepatology and Professor of Medicine at the Geisel School of Medicine at Dartmouth. Dr. Lacy’s clinical and basic science research interests focus on disorders of gastrointestinal motility, with an emphasis on irritable bowel syndrome, dyspepsia, gastroparesis, acid reflux disease, constipation, achalasia, intestinal pseudo-obstruction and visceral pain. He is the author of over 240 peer-reviewed articles on gastrointestinal motility disorders and functional bowel disorders, in addition to multiple textbook chapters.  Dr. Lacy is a reviewer for many scientific journals, and is a member of a number of different scientific organizations, including the American College of Gastroenterology, the American Gastroenterology Association, and the American Neurogastroenterology & Motility Society.  Dr. Lacy is the co-author of a book for the general public on acid reflux disease, "Healing Heartburn", is the author of "Making Sense of IBS", a book for the general public on irritable bowel syndrome, and he edited and authored the books "Curbside Consultations in IBS", “Functional and Motility Disorders of the Gastrointestinal Tract” and “Essential Disorders of the Stomach and Small Intestine” for health care providers. Dr. Lacy recently finished a 6-year tenure as co-Editor in Chief of the American Journal of Gastroenterology. He is the former Editor in Chief of Clinical and Translational Gastroenterology. Dr. Lacy was the co-Chairman for the Rome IV Committee on Functional Bowel Disorders. He is on the Board of Trustees for the Rome Committee. Dr. Lacy received his doctorate in cell biology from Georgetown University in Washington, DC, and his medical degree from the University of Maryland in Baltimore.  Dr. Lacy was a resident in Internal Medicine at the Dartmouth-Hitchcock Medical Center in Lebanon, NH, where he continued his training as Chief Resident and as a Fellow in Gastroenterology.  He is board certified in Gastroenterology and Hepatology.

  • Find a Provider

Dr. Brian E. Lacy

brian e. lacy md phd jacksonville

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

  • Chronic Idiopathic Constipation (CIC)
  • Gastroesophageal Reflux Disease (GERD)
  • Gastroparesis
  • Indigestion
  • Irritable Bowel Syndrome (IBS)
  • Bowel Incontinence
  • Painful Swallowing
  • Small Bowel Bacterial Overgrowth
  • Swallowing Difficulty
  • Childhood Volvulus
  • Esophagitis
  • Gallbladder Removal
  • Gas Bloat Syndrome
  • Gastric Dysmotility
  • Hereditary Pancreatitis
  • Morning Sickness
  • Trichohepatoenteric Syndrome
  • Viral Gastroenteritis
  • Acute Pancreatitis
  • Angiodysplasia of the Colon
  • Attenuated Familial Adenomatous Polyposis
  • Barrett Esophagus

About Dr. Brian E. Lacy

Brian Lacy is a Gastroenterologist and a Hepatologist in Jacksonville, Florida. Dr. Lacy and is highly rated in 25 conditions, according to our data. His top areas of expertise are Irritable Bowel Syndrome (IBS), Indigestion, Diarrhea, Gallbladder Removal, and Endoscopy. Dr. Lacy is currently accepting new patients.

His clinical research consists of co-authoring 207 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Brian E. Lacy it is best to call his office and ask if your insurance is accepted.

Dr. Brian E. Lacy accepts the following insurance:

  •  Florida Blue

Background & Education

Clinical research.

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

206 total publications.

Francis A. Farraye

Mayo Clinic

Mayo clinic - florida.

Francis Farraye is a Gastroenterologist and a Hepatologist in Jacksonville, Florida. Dr. Farraye has been practicing medicine for over 42 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Ulcerative Colitis, Colonoscopy, and Endoscopy. Dr. Farraye is currently accepting new patients.

Massimo Raimondo is a Gastroenterologist and an Oncologist in Jacksonville, Florida. Dr. Raimondo and is highly rated in 18 conditions, according to our data. His top areas of expertise are Hereditary Pancreatitis, Acute Pancreatitis, Chronic Pancreatitis, Endoscopy, and Colonoscopy. Dr. Raimondo is currently accepting new patients.

Jami Kinnucan is a Gastroenterologist and a Hepatologist in Jacksonville, Florida. Dr. Kinnucan has been practicing medicine for over 15 years and is highly rated in 11 conditions, according to our data. Her top areas of expertise are Ulcerative Colitis, Hemorrhagic Proctocolitis, Colitis, Endoscopy, and Colonoscopy. Dr. Kinnucan is currently accepting new patients.

Brian E Lacy PhD, MD, FACG

Professor of medicine , mayo clinic.

Brian E. Lacy, Ph.D., M.D., FACG is currently Consultant and Professor of Medicine at Mayo Clinic Jacksonville. He previously worked at the Dartmouth-Hitchcock Medical Center where he was Section Chief of Gastroenterology and Hepatology and Professor of Medicine at the Geisel School of Medicine at Dartmouth.

Dr. Lacy’s clinical and basic science research interests focus on disorders of gastrointestinal motility, with an emphasis on irritable bowel syndrome, achalasia, dyspepsia, gastroparesis, acid reflux disease, constipation, intestinal pseudo-obstruction and visceral pain. He is the author of over 200 peer-reviewed articles on gastrointestinal motility disorders and functional bowel disorders, in addition to multiple text book chapters. Dr. Lacy is a reviewer for a number of scientific journals, and is a member of a number of different scientific organizations, including the American College of Gastroenterology, the American Gastroenterology Association, and the American Neurogastroenterology & Motility Society. Dr. Lacy is the co-author of a book for the general public on acid reflux disease, "Healing Heartburn", is the author of "Making Sense of IBS", a book for the general public on irritable bowel syndrome, and edited and authored the books "Curbside Consultations in IBS", “Functional and Motility Disorders of the Gastrointestinal Tract” and “Essential Disorders of the Stomach and Small Intestine” for health care providers. Dr. Lacy is the current co-Editor in Chief of the American Journal of Gastroenterology. He is the former Editor in Chief of Clinical and Translational Gastroenterology. Dr. Lacy was the co-Chairman for the Rome IV Committee on Functional Bowel Disorders. He is on the Board of Trustees for the Rome Committee and the American College of Gastroenterology.

Dr. Lacy received his doctorate in cell biology from Georgetown University in Washington, DC, and his medical degree from the University of Maryland in Baltimore. Dr. Lacy was a resident in Internal Medicine at the Dartmouth-Hitchcock Medical Center in Lebanon, NH, where he continued his training as Chief Resident and as a Fellow in Gastroenterology. He is board certified in Gastroenterology and Hepatology.

Appearances

IMAGES

  1. Dr. Brian E. Lacy, MD

    brian e. lacy md phd jacksonville

  2. Video of the Week: Brian E. Lacy, MD, PhD, FACG, on Updates in

    brian e. lacy md phd jacksonville

  3. Brian E. Lacy, MD, PhD, FACG, on IBS and Chronic Abdominal Pain

    brian e. lacy md phd jacksonville

  4. Managing IBS-D in Primary Care: Cases to Improve Management

    brian e. lacy md phd jacksonville

  5. Medscape Gastroenterology Editorial Board

    brian e. lacy md phd jacksonville

  6. The GI Tract and COVID-19: How to Cut Risks and Keep Control

    brian e. lacy md phd jacksonville

VIDEO

  1. Se Despide Chiquilin

COMMENTS

  1. Brian E. Lacy, M.D., Ph.D.

    Dr. Lacy was the co-Chairman for the Rome IV Committee on Functional Bowel Disorders. Conditions treated Achalasia Constipation Dysphagia Functional dyspepsia Gastroesophageal reflux disease Gastroparesis Indigestion Intestinal pseudo-obstruction Irritable bowel syndrome Pelvic floor dysfunction Small intestinal bacterial overgrowth Visceral pain

  2. Dr. Brian E. Lacy, MD

    Dr. Brian E. Lacy is a gastroenterologist in Jacksonville, Florida and is affiliated with Mayo Clinic-Florida. He received his medical degree from University of Maryland School of Medicine...

  3. Dr. Brian Lacy, MD, Gastroenterology

    Dr. Brian E. Lacy, MD Is this you? Claim your profile Gastroenterology 14 Leave a review Mayo Clinic Jacksonville 4500 San Pablo Rd S, Jacksonville, FL, 32224 (904) 914-3938 OVERVIEW...

  4. Dr. Brian Lacy, MD

    New patients are generally accepted by Dr. Brian Lacy, MD on Healthgrades. To arrange an appointment, call the number on Dr. Lacy's profile. What is Dr. Brian Lacy, MD's office address? Dr. Lacy's office is located at 4500 San Pablo Rd S, Jacksonville, FL 32224.

  5. Dr. Brian E. Lacy, MD

    Dr. Brian E Lacy, MD is a health care provider primarily located in Jacksonville, FL. He has 33 years of experience. His specialties include Gastroenterology. Dr. Lacy is affiliated with Dartmouth-Hitchcock Medical Center. Quick Facts ACCEPTING NEW PATIENTS 4 18 Ratings 33 YEARS OF EXPERIENCE 18 INSURANCES ACCEPTED SPEAKS English

  6. PRIME® Faculty Biography

    Brian E. Lacy, Ph.D., M.D., FACG is currently Professor of Medicine and Consultant at Mayo Clinic Jacksonville. He previously worked at the Dartmouth-Hitchcock Medical Center where he was Section Chief of Gastroenterology and Hepatology and Professor of Medicine at the Geisel School of Medicine at Dartmouth.

  7. Publications

    Pande H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis Dig Dis Sci. 2002; 47:2664-2668. Byrnes CK, Nass PH, Shim J, Duncan MD, Lacy B, Harmon JW. Novel nuclear shuttle peptide to increase transfection efficiency in esophageal mucosal cells. J Gastrointest Surg. 2002 Jan-Feb; 6 (1):37-42 View PubMed; Lacy Be. Tegaserod Clinical ...

  8. Dr. Brian Lacy, MD

    Dr. Brian Lacy, MD - Jacksonville, FL | Gastroenterology BrianE.LacyMD Gastroenterology • Jacksonville, FL Advanced Endoscopic Interventional, Esophagus Disease Associate Professor, Medicine, Geisel School of Medicine Join to view full profile Office 4500 San Pablo Road S Jacksonville, FL 32224 Is this information wrong? Education & Training

  9. Virtual Medicine

    Brian E. Lacy, Ph.D., M.D., FACG is currently Professor of Medicine and Consultant at Mayo Clinic Jacksonville. He is the Program Director of the GI Fellowship, and is Associate Program Director for Scholarly Activities for the Medical Residency Program.

  10. Brian E. Lacy

    Brian Lacy is a Gastroenterologist and a Hepatologist in Jacksonville, Florida. Dr. Lacy and is highly rated in 25 conditions, according to our data. His top areas of expertise are Irritable Bowel Syndrome (IBS), Indigestion, Diarrhea, Gallbladder Removal, and Endoscopy. Dr. Lacy is currently accepting new patients.

  11. Brian Lacy

    Brian E. Lacy, PhD, MD, FACG, is currently Consultant and Professor of Medicine at Mayo Clinic Jacksonville. He previously worked at the Dartmouth-Hitchcock Medical Center where he was Section Chief of Gastroenterology and Hepatology and Professor of Medicine at the Geisel School of Medicine at Dartmouth.

  12. Brian E. Lacy, MD, PhD

    Dr. Brian E. Lacy has 17+ years of experience in gastroenterology. Education Brian E. Lacy, MD, PhD earned degrees of a Doctor of Medicine and Doctor of Philosophy. Licenses Brian E. Lacy, MD, PhD has been registered with the National Provider Identifier database since July 25, 2006, and his NPI number is 1518980135. Dr.

  13. Medscape Gastroenterology Editorial Board

    Brian E. Lacy, MD, PhD Mayo Clinic Jacksonville, Florida Paul Martin, MD University of Miami School of Medicine and Hospital Miami, Florida Nancy S. Reau, MD Department of Internal...

  14. Brian E. Lacy

    Brian E. Lacy, Ph.D., M.D., FACG is currently a Consultant and Professor of Medicine at Mayo Clinic Jacksonville. He previously worked at the Dartmouth-Hitchcock Medical Center where he was Section Chief of Gastroenterology and Hepatology and Professor of Medicine at the Geisel School of Medicine at Dartmouth.

  15. Brian E. Lacy, PhD, MD

    Making informed decisions on how to manage your IBS can seriously improve your quality of life and alleviate symptoms. Dr. Brian E. Lacy, PhD, is a Professor of Medicine and Chief of the Section of Gastroenterology and Hepatology at the Dartmouth-Hitchcock Medical Center in Dartmouth, NH. He also authored a book called Making Sense of IBS.

  16. Brian E. Lacy, PHD, MD

    Detailed profile of Brian E. Lacy, PHD, MD, a Gastroenterologist (Stomach & Bowel Specialist) - General Jacksonville FL. See insurances he accepts. Read ratings and reviews from other patients.

  17. PDF A Practical Approach to the Diagnosis and Treatment of Abdominal

    David J. Cangemi, MD, and Brian E. Lacy, PhD, MD Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida Corresponding author: Dr David J. Cangemi Division of Gastroenterology & Hepatology Mayo Clinic 4500 San Pablo Road Jacksonville, FL 32224 Tel: (904) 953-6970 Fax: (904) 953-6225 E-mail: [email protected] Keywords

  18. A Pragmatic Approach to the Evaluation and Treatment of Abdo ...

    Correspondence: Brian E. Lacy, PhD, MD, FACG. E-mail: [email protected] . The American Journal of Gastroenterology: May 2022 - Volume 117 - Issue 5 - p 701-705

  19. PDF Virtual Reality: A New Treatment Paradigm for Disorders of Gut-Brain

    Dr Brian E. Lacy Mayo Clinic Division of Gastroenterology & Hepatology 4500 San Pablo Road Jacksonville, FL 32224 Tel: (904) 953-6319 Fax: (904) 953-7366 E-mail: [email protected] Abstract: Disorders of gut-brain interaction (DGBIs), previously called functional bowel disorders, are prevalent, reduce patients' quality of

  20. What Gastroenterologists Should Know About Managing IBS

    Brian E. Lacy, MD, PhD Gastroenterologist Mayo Clinic, Jacksonville, Florida. Citation: Lacy BE. What Gastroenterologists Should Know About Managing IBS [published online August 22, 2019]. Gastroenterology Consultant. Diagnosing irritable bowel syndrome (IBS) entails multiple factors. One is that the patient's symptoms should be chronic; they ...

  21. The Phase 3 T3MPO-2 Study: A Gastroenterologist's Perspective

    Physician's Weekly recently spoke with Brian E. Lacy, MD, PhD, a board-certified gastroenterologist, about the phase 3 T3MPO-2 study—which assessed the efficacy of tenapanor in treating patients with irritable bowel syndrome with constipation (IBS-C)—and what the study results mean to patients with IBS-C and those who treat this population.

  22. The "Changing Landscapes" Special Edition : Official journal ...

    Guarantor of the article: Brian E. Lacy, MD, PhD, FACG. Specific author contributions: The authors contributed equally to the writing and editing of this manuscript. Financial support: None to report. Potential competing interests: The authors are the co-Editors-in-Chief of The American Journal of Gastroenterology.

  23. American Gastroenterological Association

    Brian E Lacy PhD, MD, FACG. Professor of Medicine, Mayo Clinic. Brian E. Lacy, Ph.D., M.D., FACG is currently Consultant and Professor of Medicine at Mayo Clinic Jacksonville. He previously worked at the Dartmouth-Hitchcock Medical Center where he was Section Chief of Gastroenterology and Hepatology and Professor of Medicine at the Geisel ...